Published in J Virol on February 01, 1996
Development and evaluation of an enzyme-linked immunosorbent assay based on recombinant VP2 capsids for the detection of antibodies to Aleutian mink disease virus. Clin Vaccine Immunol (2009) 1.06
Subcellular localization of Aleutian mink disease parvovirus proteins and DNA during permissive infection of Crandell feline kidney cells. J Virol (1996) 1.03
Identification of aleutian mink disease parvovirus capsid sequences mediating antibody-dependent enhancement of infection, virus neutralization, and immune complex formation. J Virol (2001) 1.03
Expression of Aleutian mink disease parvovirus capsid proteins in defined segments: localization of immunoreactive sites and neutralizing epitopes to specific regions. J Virol (1997) 0.99
The capsid proteins of Aleutian mink disease virus activate caspases and are specifically cleaved during infection. J Virol (2009) 0.95
Novel amdovirus in gray foxes. Emerg Infect Dis (2011) 0.92
Replication of Aleutian mink disease parvovirus in vivo is influenced by residues in the VP2 protein. J Virol (1999) 0.87
Aleutian mink disease virus in furbearing mammals in Nova Scotia, Canada. Acta Vet Scand (2013) 0.86
Unusual, high genetic diversity of Aleutian mink disease virus. J Clin Microbiol (1999) 0.85
Molecular epidemiology of Aleutian disease virus in free-ranging domestic, hybrid, and wild mink. Evol Appl (2012) 0.81
Driving forces behind the evolution of the Aleutian mink disease parvovirus in the context of intensive farming. Virus Evol (2016) 0.77
Progression of experimental chronic Aleutian mink disease virus infection. Acta Vet Scand (2016) 0.77
Amdoparvoviruses in small mammals: expanding our understanding of parvovirus diversity, distribution, and pathology. Front Microbiol (2015) 0.77
Aleutian mink disease virus in free-ranging mink from Sweden. PLoS One (2015) 0.76
Development of a Peptide ELISA for the Diagnosis of Aleutian Mink Disease. PLoS One (2016) 0.75
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Avoiding false positives with PCR. Nature (1989) 30.66
The pathogenesis of Aleutian disease of mink. I. In vivo viral replication and the host antibody response to viral antigen. J Exp Med (1969) 3.98
The three-dimensional structure of canine parvovirus and its functional implications. Science (1991) 3.87
Aleutian disease of mink: properties of the etiologic agent and the host responses. J Infect Dis (1968) 3.03
Rapid and reliable protocol for direct sequencing of material amplified by the polymerase chain reaction. Biotechniques (1990) 2.96
Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus. J Virol (1991) 2.50
Aleutian Disease of Mink: I. Evidence of its Viral Etiology. Can J Comp Med Vet Sci (1962) 2.18
Structure, sequence, and function correlations among parvoviruses. Virology (1993) 2.06
Characterization of Aleutian disease virus as a parvovirus. J Virol (1980) 2.04
Identification of a nonvirion protein of Aleutian disease virus: mink with Aleutian disease have antibody to both virion and nonvirion proteins. J Virol (1982) 2.02
Aleutian disease of mink: the antibody response of sapphire and pastel mink to Aleutian disease virus. J Immunol (1975) 1.95
Comparative pathogenicity of four strains of Aleutian disease virus for pastel and sapphire mink. Infect Immun (1983) 1.77
Canine host range and a specific epitope map along with variant sequences in the capsid protein gene of canine parvovirus and related feline, mink, and raccoon parvoviruses. Virology (1988) 1.76
Evidence of restricted viral replication in adult mink infected with Aleutian disease of mink parvovirus. J Virol (1988) 1.74
Nucleotide sequence and genomic organization of Aleutian mink disease parvovirus (ADV): sequence comparisons between a nonpathogenic and a pathogenic strain of ADV. J Virol (1988) 1.70
Canine and feline host ranges of canine parvovirus and feline panleukopenia virus: distinct host cell tropisms of each virus in vitro and in vivo. J Virol (1992) 1.61
Detailed transcription map of Aleutian mink disease parvovirus. J Virol (1988) 1.58
Characterization and recombination mapping of an antigenic and host range mutation of canine parvovirus. Virology (1986) 1.56
Mapping of the fibrotropic and lymphotropic host range determinants of the parvovirus minute virus of mice. J Virol (1988) 1.54
Two amino acid substitutions within the capsid are coordinately required for acquisition of fibrotropism by the lymphotropic strain of minute virus of mice. J Virol (1992) 1.51
Aleutian disease: a persistent parvovirus infection of mink with a maximal but ineffective host humoral immune response. Prog Med Virol (1986) 1.47
Purification and ultrastructure of Aleutian disease virus of mink. Nature (1975) 1.47
Antigenic relationships between canine parvovirus type 2, feline panleukopenia virus and mink enteritis virus using conventional antisera and monoclonal antibodies. Arch Virol (1982) 1.38
Passive transfer of antiviral antibodies restricts replication of Aleutian mink disease parvovirus in vivo. J Virol (1989) 1.32
Analysis of Aleutian disease of mink parvovirus infection using strand-specific hybridization probes. Intervirology (1987) 1.29
The epizootiology of aleutian disease. Front Biol (1976) 1.29
Aleutian mink disease: puzzles and paradigms. Infect Agents Dis (1994) 1.28
Analysis of experimental mink enteritis virus infection in mink: in situ hybridization, serology, and histopathology. J Virol (1990) 1.22
Acute interstitial pneumonia in mink kits: experimental reproduction of the disease. Vet Pathol (1986) 1.21
Analysis of Aleutian disease virus infection in vitro and in vivo: demonstration of Aleutian disease virus DNA in tissues of infected mink. J Virol (1985) 1.21
Parvoviral target cell specificity: acquisition of fibrotropism by a mutant of the lymphotropic strain of minute virus of mice involves multiple amino acid substitutions within the capsid. Virology (1991) 1.18
Replication of Aleutian mink disease parvovirus in lymphoid tissues of adult mink: involvement of follicular dendritic cells and macrophages. J Virol (1991) 1.17
Aleutian disease in mink: virology, immunology and pathogenesis. J Rheumatol (1974) 1.17
Aleutian disease of mink. Prevention of lesions by immunosuppression. Am J Pathol (1972) 1.13
Characterization of the Aleutian disease virus genome and its intracellular forms. J Virol (1983) 1.13
Protides of the Mustelidae: immunoresponse of mustelids to Aleutian mink disease virus. Am J Vet Res (1978) 1.12
Acute interstitial pneumonia in mink kits inoculated with defined isolates of Aleutian mink disease parvovirus. Vet Pathol (1994) 1.11
Nucleotide sequence of feline panleukopenia virus: comparison with canine parvovirus identifies host-specific differences. J Gen Virol (1990) 1.09
Aleutian mink disease parvovirus infection of mink macrophages and human macrophage cell line U937: demonstration of antibody-dependent enhancement of infection. J Virol (1993) 1.09
Nucleotide sequence of the 5'-terminal palindrome of Aleutian mink disease parvovirus and construction of an infectious molecular clone. J Virol (1990) 1.08
Characteristics of inapparent Aleutian disease virus infection in mink. Res Vet Sci (1978) 1.07
Analysis of parvovirus infections using strand-specific hybridization probes. Virus Res (1989) 1.06
The NS and capsid genes determine the host range of porcine parvovirus. Virology (1992) 1.05
Aleutian disease in ferrets. Infect Immun (1982) 1.04
Royal pastel mink respond variously to inoculation with Aleutian disease virus of low virulence. J Virol (1984) 1.04
A rapid method of sample preparation for detection of DNA viruses in human serum by polymerase chain reaction. J Virol Methods (1991) 1.04
Pathogenesis of disease caused by Aleutian mink disease parvovirus. APMIS Suppl (1990) 1.04
Characterization of chimeric full-length molecular clones of Aleutian mink disease parvovirus (ADV): identification of a determinant governing replication of ADV in cell culture. J Virol (1993) 1.03
Sequence comparison of the non-structural genes of four different types of Aleutian mink disease parvovirus indicates an unusual degree of variability. Arch Virol (1994) 1.00
Characterization of antigenic variation among mink enteritis virus isolates. Am J Vet Res (1984) 0.99
Pathogenesis of feline panleukopenia virus in susceptible newborn kittens I. Clinical signs, hematology, serology, and virology. Infect Immun (1971) 0.99
Nucleotide sequence analysis of Aleutian mink disease parvovirus shows that multiple virus types are present in infected mink. J Virol (1991) 0.98
Comparisons of feline panleukopenia virus, canine parvovirus, raccoon parvovirus, and mink enteritis virus and their pathogenicity for mink and ferrets. Am J Vet Res (1987) 0.97
Hypergammaglobulinemia in ferrets with lymphoproliferative lesions (Aleutian disease). Am J Vet Res (1967) 0.97
Aleutian mink disease parvovirus infection of mink peritoneal macrophages and human macrophage cell lines. J Virol (1993) 0.96
Temporal replication of the Pullman strain of Aleutian disease virus in royal pastel mink. J Virol (1985) 0.92
Experimental transmission of Aleutian disease virus (ADV) to different animal species. Acta Pathol Microbiol Immunol Scand B (1985) 0.91
Detection of Aleutian disease virus DNA in tissues of naturally infected mink. J Gen Virol (1988) 0.90
Pathogenesis of Aleutian mink disease parvovirus infection: effects of suppression of antibody response on viral mRNA levels and on development of acute disease. J Virol (1994) 0.86
Interstitial nephritis in Aleutian mink disease. Possible role of cell-mediated immunity against virus-infected tubular epithelial cells. Am J Pathol (1994) 0.86
Feline Panleukopenia. I. Pathogenesis in germfree and specific pathogen-free cats. Vet Pathol (1977) 0.85
Parvovirus infections: features reminiscent of AIDS. Ann N Y Acad Sci (1984) 0.84
Raccoons are not susceptible to canine parvovirus. J Am Vet Med Assoc (1982) 0.82
Replication of Aleutian disease virus in mink lymphocytes infected in vitro. Intervirology (1986) 0.82
Restricted viral antibody specificity in many ferrets infected with the ferret Aleutian disease parvovirus. Brief report. Arch Virol (1987) 0.81
Suspected Aleutian disease in a wild otter (Lutra lutra). Vet Rec (1989) 0.79
Violet mink develop an acute disease after experimental infection with Aleutian disease virus (ADV) isolate ADV SL3. Zentralbl Veterinarmed B (1990) 0.78
Variations in the Effectiveness of Commercial Infectious Feline Enteritis Vaccines in Preventing Virus Enteritis of Mink. Can Vet J (1960) 0.76
Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med (1996) 7.06
Control of specific gene expression in higher organisms. Expression of mammalian genes may be controlled by repressors acting on the translation of messenger RNA. Science (1969) 4.81
Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group. Ann Intern Med (1993) 4.03
Deprivation payments to general practitioners: limitations of census data. BMJ (1996) 3.98
Using data from the 1991 census. BMJ (1995) 3.63
Guidelines on the management of common bile duct stones (CBDS). Gut (2008) 3.58
Natural infection of Suffolk sheep with scrapie virus. J Infect Dis (1982) 3.42
Early predictors of career achievement in academic medicine. JAMA (1992) 3.35
Pathogenesis of scrapie virus infection in the mouse. J Infect Dis (1967) 3.34
Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages. J Virol (1991) 3.28
emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis (1999) 3.12
Aleutian disease of mink: properties of the etiologic agent and the host responses. J Infect Dis (1968) 3.03
A prospective study of delirium in hospitalized elderly. JAMA (1990) 3.02
Recombination between genes encoding major outer surface proteins A and B of Borrelia burgdorferi. Mol Microbiol (1992) 3.01
The Index of Multiple Deprivation 2000 and accessibility effects on health. J Epidemiol Community Health (2004) 2.92
Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy (2007) 2.88
Polymerase chain reaction analyses identify two distinct classes of Borrelia burgdorferi. J Clin Microbiol (1991) 2.71
Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology (1995) 2.55
Postcodes and the 1991 census of population: issues, problems and prospects. Trans Inst Br Geogr (1992) 2.46
On-site HIV testing in resource-poor settings: is one rapid test enough? AIDS (1997) 2.39
Plasmid location of Borrelia purine biosynthesis gene homologs. J Bacteriol (1994) 2.36
Functional recovery in parkinsonian monkeys treated with GDNF. Nature (1996) 2.35
Estrogen therapy and variable-resistance weight training increase bone mineral in surgically menopausal women. J Bone Miner Res (1991) 2.33
Ocular delayed hypersensitivity: a pathogenetic mechanism of chlamydial-conjunctivitis in guinea pigs. Proc Natl Acad Sci U S A (1986) 2.24
Infectious leukoencephalomyelitis of young goats. J Infect Dis (1974) 2.23
Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol (1994) 2.21
Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. J Exp Med (1993) 2.07
Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci (2001) 2.07
Characterization of Aleutian disease virus as a parvovirus. J Virol (1980) 2.04
Identification of a nonvirion protein of Aleutian disease virus: mink with Aleutian disease have antibody to both virion and nonvirion proteins. J Virol (1982) 2.02
Oligopeptide permease in Borrelia burgdorferi: putative peptide-binding components encoded by both chromosomal and plasmid loci. Microbiology (1998) 2.01
The Borrelia burgdorferi circular plasmid cp26: conservation of plasmid structure and targeted inactivation of the ospC gene. Mol Microbiol (1997) 1.99
Difficulties in recognizing one's own incompetence: novice physicians who are unskilled and unaware of it. Acad Med (2001) 1.98
The running tie-over dressing. Plast Reconstr Surg (2000) 1.96
Aleutian disease of mink: the antibody response of sapphire and pastel mink to Aleutian disease virus. J Immunol (1975) 1.95
Synthesis and induction of tyrosine aminotransferase in synchronized hepatoma cells in culture. Proc Natl Acad Sci U S A (1969) 1.95
Target recognition and visual maps in the thalamus of achiasmatic dogs. Nature (1994) 1.94
Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes. J Virol (1996) 1.94
Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience (2001) 1.91
Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain (1997) 1.90
Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg (1990) 1.90
Terpenoid secondary metabolism in Arabidopsis thaliana: cDNA cloning, characterization, and functional expression of a myrcene/(E)-beta-ocimene synthase. Arch Biochem Biophys (2000) 1.89
Isolation of eastern equine encephalitis virus from Aedes albopictus in Florida. Science (1992) 1.89
Virologic and neurohistologic findings in dairy goats affected with natural scrapie. Vet Pathol (1980) 1.88
A novel mechanism for skeletal resistance in uremia. Kidney Int (2000) 1.88
Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res (2000) 1.83
Tight junction proteins ZO-1, ZO-2, and occludin along isolated renal tubules. Kidney Int (2000) 1.82
Comorbidity in ADHD: implications for research, practice, and DSM-V. J Am Acad Child Adolesc Psychiatry (1997) 1.81
Transcriptional regulation of the mosquito vitellogenin gene via a blood meal-triggered cascade. Gene (2001) 1.81
Linking community-based blood pressure measurement to clinical care: a randomized controlled trial of outreach and tracking by community health workers. Am J Public Health (1999) 1.81
Directed insertion of a selectable marker into a circular plasmid of Borrelia burgdorferi. J Bacteriol (1996) 1.78
Characterization of cytokine-induced hyperalgesia. Brain Res (1994) 1.78
Comparative pathogenicity of four strains of Aleutian disease virus for pastel and sapphire mink. Infect Immun (1983) 1.77
Establishing a workplace antiretroviral therapy programme in South Africa. AIDS Care (2007) 1.75
Evidence of restricted viral replication in adult mink infected with Aleutian disease of mink parvovirus. J Virol (1988) 1.74
Identification of group B streptococcal Sip protein, which elicits cross-protective immunity. Infect Immun (2000) 1.73
A multilevel analysis of the effects of rurality and social deprivation on premature limiting long term illness. J Epidemiol Community Health (2001) 1.72
Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand. Vaccine (2007) 1.72
Nucleotide sequence and genomic organization of Aleutian mink disease parvovirus (ADV): sequence comparisons between a nonpathogenic and a pathogenic strain of ADV. J Virol (1988) 1.70
Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res (1997) 1.69
What predicts failed cannulation and therapy at ERCP? Results of a large-scale multicenter analysis. Endoscopy (2012) 1.68
Issues in the measurement of satisfaction with treatment. Am J Manag Care (1997) 1.67
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67
Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen. J Clin Invest (1996) 1.64
Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis (1999) 1.63
Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial. Ann Intern Med (1980) 1.61
Homology between Borrelia burgdorferi OspC and members of the family of Borrelia hermsii variable major proteins. Gene (1994) 1.61
Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol (2000) 1.61
Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett (1995) 1.60
ESTIMATION OF BLOOD VOLUME FROM CHANGE IN BLOOD SPECIFIC GRAVITY FOLLOWING A PLASMA INFUSION. J Clin Invest (1946) 1.59
Detailed transcription map of Aleutian mink disease parvovirus. J Virol (1988) 1.58
Position-dependent variegation of globin transgene expression in mice. Proc Natl Acad Sci U S A (1995) 1.58
The generation of spatial population distributions from census centroid data. Environ Plan A (1989) 1.57
Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation (1999) 1.57
Meningococcal disease in Auckland, July 1992 - June 1994. N Z Med J (1999) 1.55
The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. Kidney Int (2007) 1.53
Protein trans-splicing and cyclization by a naturally split intein from the dnaE gene of Synechocystis species PCC6803. J Biol Chem (2000) 1.53
Impaired water excretion in myxedema. Am J Med (1971) 1.53
Japanese encephalitis among hospitalized pediatric and adult patients with acute encephalitis syndrome in Hanoi, Vietnam 1995. Am J Trop Med Hyg (1998) 1.52
Linkage of the 1981 and 1991 U.K. censuses using surface modelling concepts. Environ Plan A (1995) 1.52
Cholera on the Texas Gulf Coast. JAMA (1982) 1.50
Tenm, a Drosophila gene related to tenascin, is a new pair-rule gene. EMBO J (1994) 1.48
Postpolio syndrome in New Zealand: a survey of 700 polio survivors. N Z Med J (1993) 1.47
A randomized trial of misoprostol and oxytocin for induction of labor: safety and efficacy. Obstet Gynecol (1997) 1.47
Fatal shoulder dystocia: a review of 56 cases reported to the Confidential Enquiry into Stillbirths and Deaths in Infancy. Br J Obstet Gynaecol (1998) 1.46
Isolation of a virus from the lungs of Montana sheep affected with progressive pneumonia. Virology (1968) 1.46
Esophageal symptoms, manometry, and histology before and after antireflux surgery: a long-term follow-up study. Gastroenterology (1979) 1.46
Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44
Partial purification and evidence for multiple molecular forms of the scrapie agent. Biochemistry (1978) 1.42
Control of degradation and synthesis of induced tyrosine aminotransferase studied in hepatoma cells in culture. Nature (1969) 1.42
Argon laser trabecular surgery in uncontrolled phakic open angle glaucoma. Ophthalmology (1981) 1.42